Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chromatin complex dependencies reveal novel targeting opportunities in leukemia [300K]

ABSTRACT: Combinatorial CRISPRko screening data in leukemia cell lines

ORGANISM(S): synthetic construct Homo sapiens

PROVIDER: GSE215347 | GEO | 2022/12/16

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Chromatin complex dependencies reveal novel targeting opportunities in leukemia [40k]

Project description:Combinatorial CRISPRko screening data in leukemia cell lines

2022-12-16 | GSE215346 | GEO

Chromatin complex dependencies reveal targeting opportunities in leukemia

Project description:Chromatin regulators are frequently mutated in human cancer and are attractive drug targets. They include diverse proteins that share functional domains and assemble into related multi-subunit complexes. To investigate functional relationships among these regulators, here we apply combinatorial CRISPR knockouts (KOs) to test over 35,000 gene-gene pairings in leukemia cells, using a library of over 300,000 constructs. Top pairs that demonstrate either compensatory non-lethal interactions or synergistic lethality enrich for paralogs and targets that occupy the same protein complex. The screen highlights protein complex dependencies not apparent in single KO screens, for example MCM histone exchange, the nucleosome remodeling and deacetylase (NuRD) complex, and HBO1 (KAT7) complex. We explore two approaches to NuRD complex inactivation. Paralog and non-paralog combinations of the KAT7 complex emerge as synergistic lethal and specifically nominate the ING5 PHD domain as a potential therapeutic target when paired with other KAT7 complex member losses. These findings highlight the power of combinatorial screening to provide mechanistic insight and identify therapeutic targets within redundant networks.

2022-12-16 | GSE215348 | GEO

Chromatin complex dependencies reveal novel targeting opportunities in leukemia [RNA-seq]

Project description:Knockout of NuRD complex members in THP-1, Reh, and MV4-11 leukemia cell lines.

2022-12-16 | GSE214773 | GEO

Chromatin complex dependencies reveal targeting opportunities in leukemia.

| S-EPMC9883437 | biostudies-literature

Chromatin complex dependencies reveal targeting opportunities in leukemia

Project description:Chromatin complex dependencies reveal targeting opportunities in leukemia

| PRJNA889822 | ENA

Chromatin complex dependencies reveal novel targeting opportunities in leukemia [40k]

Project description:Chromatin complex dependencies reveal novel targeting opportunities in leukemia [40k]

| PRJNA889830 | ENA

Chromatin complex dependencies reveal novel targeting opportunities in leukemia [300K]

Project description:Chromatin complex dependencies reveal novel targeting opportunities in leukemia [300K]

| PRJNA889829 | ENA

Chromatin complex dependencies reveal novel targeting opportunities in leukemia [RNA-seq]

Project description:Chromatin complex dependencies reveal novel targeting opportunities in leukemia [RNA-seq]

| PRJNA887061 | ENA

Rodrigues2019 - A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia

Project description:THis is a simple ordinary differential equation model describing chemoimmunotherapy of chronic lymphocytic leukemia, including descriptions of the combinatorial effects of chemotherapy and adoptive cellular immunotherapy.

2024-09-02 | BIOMD0000000879 | BioModels

Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells

Project description:HSP90 inhibitors (HSP90i) have not entered routinely in the clinics, primarily due to the associated resistance via heat shock response (HSR) induction and dose limiting toxicity. In this study, we employed genetic KO and knockdown (KD) models of HSP90 isoforms (α and β) for extensive multi-omics-based in vitro and in vivo characterization and identified HSP90α as the primary driver of malignancy of the two isoforms in BCR-ABL1+ leukemia cells. Notably, combinatorial ex vivo drug sensitivity screenings identified CDK7 inhibitors (CDK7i) as drugs synergizing with HSP90α inhibition.

2024-01-26 | PXD041871 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data